ChandranVKumarasingheSP. Macular pigmentation of uncertain aetiology revisited: two case reports and a proposed algorithm for clinical classification. Australas J Dermatol. 2017;58:45-49.
2.
Robles-MendezJCRizo-FriasPHerz-RuelasMEPandyaAGOcampo CandianiJ. Lichen planus pigmentosus and its variants: review and update. Int J Dermatol. 2018;57(5):505-514.
3.
ZaynounSRubeizNKibbiAG. Ashy dermatoses—a critical review of the literature and a proposed simplified clinical classification. Int J Dermatol. 2008;47:542-524.
4.
ChangSEKimHWShinJMet al. Clinical and histological aspect of erythema dyschromicum perstans in Korea: a review of 68 cases. J Dermatol. 2015;42:1053-1057.
5.
KroonMWWindBSMeestersAAet al. Non-ablative 1550 nm fractional laser therapy not effective for erythema dyschromicum perstans and postinflammatory hyperpigmentation: a pilot study. J Dermatol Treat. 2012;23:339-44.
6.
Al-MutairiNEl-KhalawanyM. Clinicopathological characteristics of lichen planus pigmentosus and its response to tacrolimus ointment: an open label, non-randomized, prospective study. J Eur Acad Dermatol Venereol. 2010;24:535-540.
7.
SindhuraKBVinayKKumaranMSSaikiaUNParsadD. Lichen planus pigmentosus: a retrospective clinico-epidemiologic study with emphasis on the rare follicular variant. J Eur Acad Dermatol Venereol. 2016;30:e142-e144.
8.
VermaPPandhiD. Topical tacrolimus and oral dapsone combination regimen in lichen planus pigmentosus. Skinmed. 2015;13:351-354.
9.
MuthuSKNarangTSaikiaUNKanwarAJParsadDDograS. Low-dose oral isotretinoin therapy in lichen planus pigmentosus: an open-label non-randomized prospective pilot study. Int J Dermatol. 2016;55:1048-1054.
10.
MohamedMKorbiMHammediFet al. Lichen planus pigmentosus inversus: a series of 10 Tunisian patients. Int J Dermatol. 2016;55:1088-1091.
